Literature DB >> 3699101

Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.

P Worms, J Martinez, C Briet, B Castro, K Biziere.   

Abstract

The behavioural effect of intrastriatally injected cholecystokinin sulphated octapeptide (CCK-8S), and its interactions with the antagonists Z-CCK-(27-32)NH2 and proglumide, were investigated in mice. When injected into the right striatum, CCK-8S (0.05-1 ng) induced contralateral rotations, as did the dopamine agonist apomorphine. Non-sulphated CCK-8 was inactive and sulphated desamino-CCK-7 was only weakly active in this respect. CCK-8S-induced turning was antagonized by co-injected Z-CCK-(27-32)NH2 (0.01-10 ng) or proglumide (0.1-1 micrograms), as well as by intraperitoneal injection of the neuroleptic drug haloperidol. These data suggest that CCK-8S may, in these conditions, stimulate dopamine-mediated neurotransmission, and that Z-CCK-(27-32)NH2, in addition to its peripheral effect, is also a very potent CCK antagonist at the striatal level.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699101     DOI: 10.1016/0014-2999(86)90260-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Cyclic cholecystokinin analogues with high selectivity for central receptors.

Authors:  B Charpentier; D Pelaprat; C Durieux; A Dor; M Reibaud; J C Blanchard; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.

Authors:  P Worms; J P Kan; C G Wermuth; K Biziere
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

3.  Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice.

Authors:  B Stauch Slusher; K C Rissolo; P F Jackson; L M Pullan
Journal:  J Neural Transm Gen Sect       Date:  1994

4.  Characterization of [3H]cholecystokinin octapeptide binding to mouse brain synaptosomes: effects of neuroleptics.

Authors:  Y Hama; M Ebadi
Journal:  Neurochem Res       Date:  1987-08       Impact factor: 3.996

5.  Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.

Authors:  F H Marshall; S Barnes; R D Pinnock; J Hughes
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

6.  Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist.

Authors:  M Poncelet; M Arnone; M Heaulme; N Gonalons; C Gueudet; V Santucci; O Thurneyssen; P Keane; D Gully; G Le Fur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

7.  Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists.

Authors:  M Poncelet; C Gueudet; D Gully; P Soubrié; G Le Fur
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.